KORU Medical CCO Adam Kalbermatten Buys 32,000 Shares

What Happened
Adam R. Kalbermatten, Chief Commercial Officer of KORU Medical Systems, purchased 32,000 shares in an open-market transaction on September 8, 2026. The shares were acquired at $3.16 per share for a total purchase price of $101,120. This was a purchase (transaction code P), which investors often view as a more informative insider action than routine sales.

Key Details

• Transaction date: 2026-09-08; filing date: 2026-09-09 (appears timely).
• Transaction type: Open market purchase (Code P).
• Shares purchased: 32,000 at $3.16 each.
• Total value: $101,120.
• Shares owned after transaction: Not specified in the filing.
• Notes/footnotes: Filing states power of attorney has been previously filed and includes standard disclaimer language that the filing is not an admission of beneficial ownership or filing obligation.

Context
Purchases by executives can signal confidence but are not proof of future performance; they should be considered alongside other information (company results, trends, and broader insider activity). There were no option exercises, awards, gifts, or tax-withholding events reported in this filing.